pembrolizumab,ict01
merck,imcheck therapeutics
['ict01', 'eviction', 'pembro']
presents positive safety and efficacy data from the completed phase 1 dose escalation cohort of ict01 plus pembrolizumab in the eviction trial at esmo congress 2022 
Pharmaceutical News - Direct Information